Closer to A Cure

With recent advances in the treatments of blood cancers, UCLA Health and the Leukemia & Lymphoma Society are visiting communities across Southern California to discuss these emerging therapies.

Register and join us in person or online! Dinner will be provided to guests attending in person.

Lecture Series, Times and Locations

November 6th, 6pm-7:30pm
DLBCL and Follicular Lymphomas
WeSpark Cancer Support Center
13522 Ventura Blvd, Sherman Oaks, CA 901423

Join UCLA oncologist Monica Mead, MD, for an overview of treatment options for patients diagnosed with diffuse large B-cell lymphoma (DLBCL) and other follicular lymphomas. DLBCL is the most common type of non-Hodgkin lymphoma (NHL) in the US, accounting for about 1 out of every 3 lymphomas.

Click the "Play" button in the YouTube window below to watch the live stream.

Recent Events

CAR T- Cell Therapy

UCLA oncologist Joshua Sasine, MD, PhD, talks about the latest advancements in CAR T-cell therapy at UCLA.

Multiple Myeloma

UCLA oncologist Sarah Larson, MD, covers the latest treatment options and clinical trials availanle to patients with myeloma.

Advances in Treatments of Blood Cancers (including Immunotherapy)

UCLA oncologist Herbert Eradat, MD, gives an overview of the latest advancements in immunotherapy and other treatments of blood cancers.

Blood Cancer 101: What You Need to Know

UCLA oncologists Gary Schiller, MD and Patricia Young, MD, and social worker Rebecca Pittenger, LCSW, give an overview of blood cancers, what causes them, symptoms and diagnosis. Our specialists cover the latest treatment options and clinical trials available to patients in a conversation moderated by Leila Evangelista from the Leukemia & Lymphoma Society.